UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine

Clinical chemistry (Baltimore, Md.), 2018-04, Vol.64 (4), p.645-655

2018

Volltextzugriff (PDF)

Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction

Circulation (New York, N.Y.), 2016-11, Vol.134 (20), p.1532-1541

2016

Volltextzugriff (PDF)

Clinical chemistry score misses fewer deaths as compared to troponin T alone in a United States emergency department population

Clinical biochemistry, 2021-09, Vol.95, p.91-92

2021

Volltextzugriff (PDF)

Impact of switching total bilirubin assays on the classification of neonates at high risk for hyperbilirubinemia

Clinical chemistry and laboratory medicine, 2023-08, Vol.61 (9), p.e175-e178

2023

Volltextzugriff (PDF)

Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction

Heart (British Cardiac Society), 2016-08, Vol.102 (16), p.1270-1278

2016

Volltextzugriff (PDF)

Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers

Clinical chemistry (Baltimore, Md.), 2021-05, Vol.67 (5), p.730-735

2021

Volltextzugriff (PDF)

High-Sensitivity Cardiac Troponin Publications during the COVID-19 Pandemic (2020-2022)

Journal of cardiovascular development and disease, 2022-12, Vol.10 (1), p.5

Kavsak, Peter A

2022

Volltextzugriff (PDF)

Using logistic regression models to investigate the effects of high-sensitivity cardiac troponin T confounders on ruling in acute myocardial infarction

Clinical chemistry and laboratory medicine, 2023-06, Vol.61 (7), p.1335-1342

2023

Volltextzugriff (PDF)

Editorial commentary: High-sensitivity cardiac troponin: Like every new tool there is a learning curve

Trends in cardiovascular medicine, 2017-01, Vol.27 (1), p.48-50

Kavsak, Peter A., PhD

2017

Volltextzugriff (PDF)

Monitoring the “high” in high-sensitivity cardiac troponin assays for patient risk stratification

International journal of cardiology, 2025-01, Vol.418, p.132654, Article 132654

Kavsak, Peter A.

2025

Volltextzugriff (PDF)

Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations

The Annals of thoracic surgery, 2017-08, Vol.104 (2), p.613-620

2017

Volltextzugriff (PDF)

The PROVE-HF Study: Additional Proof for the Inclusion of the Manufacturer's Name When Reporting B-Type Natriuretic Peptide Results

Clinical chemistry (Baltimore, Md.), 2022-11, Vol.68 (11), p.1353-1355

Kavsak, Peter A

2022

Volltextzugriff (PDF)

Lot-to-lot bias for high-sensitivity cardiac troponin I concentrations ≥1000 ng/L

Clinical chemistry and laboratory medicine, 2023-06, Vol.61 (7), p.e105-e107

Kavsak, Peter A

2023

Volltextzugriff (PDF)

Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection

Clinical chemistry (Baltimore, Md.), 2022-07, Vol.68 (8), p.1019-1020

Kavsak, Peter A

2022

Volltextzugriff (PDF)

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)

Clinical chemistry and laboratory medicine, 2019-04, Vol.57 (5), p.633-640

2019

Volltextzugriff (PDF)

Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department

Canadian Medical Association journal (CMAJ), 2018-08, Vol.190 (33), p.E974-E984

2018

Volltextzugriff (PDF)

Measurement in different sample types may aid in detecting interferences and macrocomplexes affecting cardiac troponin measurements

Clinical chemistry and laboratory medicine, 2022-02, Vol.60 (3), p.66-67

Kavsak, Peter A

2022

Volltextzugriff (PDF)

Discordant High-Sensitivity Cardiac Troponin I Concentrations in the General Population

Clinical chemistry (Baltimore, Md.), 2024-03, Vol.70 (3), p.562-564

2024

Volltextzugriff (PDF)

Additional approaches for identifying non-reproducible cardiac troponin results

Clinical chemistry and laboratory medicine, 2021-06, Vol.59 (7), p.e267-e270

Kavsak, Peter A.

2021

Volltextzugriff (PDF)

High-sensitivity cardiac troponin risk-cutoffs for acute cardiac outcomes at emergency department presentation

Canadian journal of cardiology, 2017-07, Vol.33 (7), p.898-903

2017

Volltextzugriff (PDF)

The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction

International journal of cardiology, 2024-05, Vol.403, p.131898-131898, Article 131898

2024

Volltextzugriff (PDF)

External Quality Assessment Testing Near the Limit of Detection for High-Sensitivity Cardiac Troponin Assays

Clinical chemistry (Baltimore, Md.), 2018-09, Vol.64 (9), p.1402-1404

Kavsak, Peter A

2018

Volltextzugriff (PDF)

Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies

Clinical chemistry (Baltimore, Md.), 2006-05, Vol.52 (5), p.812-818

2006

Volltextzugriff (PDF)

Imprecision and Delta Criteria for a New ESC 0/2-Hour Algorithm

Clinical chemistry (Baltimore, Md.), 2022-05, Vol.68 (5), p.721-722

2022

Volltextzugriff (PDF)

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer

CJC open (Online), 2023-08, Vol.5 (8), p.658-660

2023

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

Englisch
(328)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction

Clinical chemistry score misses fewer deaths as compared to troponin T alone in a United States emergency department population

Impact of switching total bilirubin assays on the classification of neonates at high risk for hyperbilirubinemia

Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction

High-Sensitivity Cardiac Troponin Publications during the COVID-19 Pandemic (2020-2022)

Using logistic regression models to investigate the effects of high-sensitivity cardiac troponin T confounders on ruling in acute myocardial infarction

Editorial commentary: High-sensitivity cardiac troponin: Like every new tool there is a learning curve

Monitoring the “high” in high-sensitivity cardiac troponin assays for patient risk stratification

Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations

The PROVE-HF Study: Additional Proof for the Inclusion of the Manufacturer's Name When Reporting B-Type Natriuretic Peptide Results

Lot-to-lot bias for high-sensitivity cardiac troponin I concentrations ≥1000 ng/L

Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)

Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department

Measurement in different sample types may aid in detecting interferences and macrocomplexes affecting cardiac troponin measurements

Discordant High-Sensitivity Cardiac Troponin I Concentrations in the General Population

Additional approaches for identifying non-reproducible cardiac troponin results

High-sensitivity cardiac troponin risk-cutoffs for acute cardiac outcomes at emergency department presentation

The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction

External Quality Assessment Testing Near the Limit of Detection for High-Sensitivity Cardiac Troponin Assays

Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies

Imprecision and Delta Criteria for a New ESC 0/2-Hour Algorithm

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer

Suchergebnisse filtern